Mexico Genome Editing Market Size & Outlook, 2023-2030
Mexico genome editing market, 2018-2030 (US$M)
Related Markets
Mexico genome editing market highlights
- The Mexico genome editing market generated a revenue of USD 115.3 million in 2023 and is expected to reach USD 315.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 15.5% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 115.3 million |
| Market revenue in 2030 | USD 315.4 million |
| Growth rate | 15.5% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.4% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 660.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 45.1% in 2023. Horizon Databook has segmented the Mexico genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
The developing biotechnology sector in Mexico is one of the major factors expected to drive market growth. Several companies & institutes are attracted to the Mexican market and making continuous efforts through joint ventures with local institutes to enter the market.
For instance,. Arizona State University (ASU), the U.S., and Mexican Biosafety Association (AmexBio) entered into a collaboration to strengthen biosafety & biosecurity initiatives across U.S and Mexico. This initiative provides a platform to share best practices, research collaboration, training programs, and the latest information on emerging biological technologies.
In addition, ASU is committed to helping AmexiBio develop a compliance infrastructure to address emerging technologies such as genome editing. Furthermore, supportive government initiatives are expected to drive market growth in this region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico genome editing market size, by technology, 2018-2030 (US$M)
Mexico Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
